Molecular Partners AG
Molecular Partners AG (MOLN) Revenue
Annual & quarterly revenue history · segment & region breakdown
MOLN · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMolecular Partners AG trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2013 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -100.00% |
| 2024-12-31 | $0.00B | -$0.00B | -29.38% |
| 2023-12-31 | $0.01B | -$0.18B | -96.29% |
| 2022-12-31 | $0.19B | +$0.18B | +1931.68% |
| 2021-12-31 | $0.01B | -$0.00B | -0.15% |
| 2020-12-31 | $0.01B | -$0.01B | -54.16% |
| 2019-12-31 | $0.02B | +$0.01B | +96.84% |
| 2018-12-31 | $0.01B | -$0.01B | -48.27% |
| 2017-12-31 | $0.02B | -$0.00B | -13.13% |
| 2016-12-31 | $0.02B | -$0.01B | -20.88% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Molecular Partners AG receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Molecular Partners AG reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CHF.
Data sourced from Molecular Partners AG's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MOLN revenue · 4 questionsMOLN's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Molecular Partners AG SEC filings · GAAP · Molecular Partners AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026